Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 10 2020
Historique:
received: 23 11 2018
accepted: 27 08 2020
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 9 3 2021
Statut: epublish

Résumé

Hyperinflation contributes to dyspnea intensity in COPD. Little is known about the molecular mechanisms underlying hyperinflation and how inhaled corticosteroids (ICS) affect this important aspect of COPD pathophysiology. To investigate the effect of ICS/long-acting β

Identifiants

pubmed: 33060632
doi: 10.1038/s41598-020-72551-0
pii: 10.1038/s41598-020-72551-0
pmc: PMC7562702
doi:

Substances chimiques

Adrenergic beta-2 Receptor Agonists 0
Bronchodilator Agents 0
Placebos 0
Budesonide 51333-22-3
Formoterol Fumarate W34SHF8J2K

Banques de données

ClinicalTrials.gov
['NCT01351792', 'NCT00848406', 'NCT00158847']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17415

Références

Nat Genet. 2013 May;45(5):542-545
pubmed: 23563608
Am J Respir Crit Care Med. 2013 May 1;187(9):933-42
pubmed: 23471465
Proc Am Thorac Soc. 2006 Apr;3(2):180-4
pubmed: 16565429
Eur Respir J. 2004 Jun;23(6):932-46
pubmed: 15219010
Proc Am Thorac Soc. 2011 May;8(2):173-9
pubmed: 21543797
Int J Chron Obstruct Pulmon Dis. 2006;1(3):219-33
pubmed: 18046859
Respir Med. 2005 Nov;99(11):1418-24
pubmed: 15894479
Proc Am Thorac Soc. 2005;2(4):258-66; discussion 290-1
pubmed: 16267346
Physiol Rev. 2007 Jul;87(3):1047-82
pubmed: 17615396
Eur Respir J. 1995 Aug;8(8):1398-420
pubmed: 7489808
Am J Respir Cell Mol Biol. 2014 May;50(5):912-22
pubmed: 24298892
Chest. 2006 Sep;130(3):647-56
pubmed: 16963658
Thorax. 2014 Jan;69(1):14-23
pubmed: 23925644
Thorax. 2013 Aug;68(8):709-16
pubmed: 23370438
Eur Respir J. 1999 Jan;13(1):190-6
pubmed: 10836347

Auteurs

Alen Faiz (A)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pathology & Medical Biology, Section Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Kai Imkamp (K)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. k.imkamp@umcg.nl.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. k.imkamp@umcg.nl.

Erica van der Wiel (E)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Ilse M Boudewijn (IM)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Gerard H Koppelman (GH)

GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Corry-Anke Brandsma (CA)

GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Huib A M Kerstjens (HAM)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Wim Timens (W)

GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Sebastiaan Vroegop (S)

Department of Pulmonary Diseases, Martini Hospital Groningen, Groningen, The Netherlands.

Henk R Pasma (HR)

Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, The Netherlands.

Wim G Boersma (WG)

Department of Pulmonary Diseases, Medical Center Alkmaar, Alkmaar, The Netherlands.

Pascal Wielders (P)

Department of Pulmonary Diseases, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.

Frank van den Elshout (F)

Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, The Netherlands.

Khaled Mansour (K)

Department of Pulmonary Diseases, Orbis Concern, Sittard, The Netherlands.

Katrina Steiling (K)

Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Avrum Spira (A)

Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Marc E Lenburg (ME)

Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Irene H Heijink (IH)

GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Department of Pathology & Medical Biology, Section Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Dirkje S Postma (DS)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Maarten van den Berge (M)

Department of Pulmonology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH